Per Westermark

31.6k citations
402 papers · 24.8k · 8 hit papers · h-index 82

Impact in

  • Physiology top 0.05%
    • Alzheimer's disease research and treatments
  • Nephrology top 0.2%
    • Parathyroid Disorders and Treatments

Papers in

    • Amyloidosis: Diagnosis, Treatment, Outcomes 233
    • Prion Diseases and Protein Misfolding 29
    • Alzheimer's disease research and treatments 130

Per Westermark

391 papers receiving 23.8k citations

Per Westermark's Hit Papers

Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee 2022 · 199 citations
1990+13+26Years since publication250500750

Peers

Per Westermark
Comparison fields: 5 of 159
  • Physiology 9.3k
  • Nephrology 1.9k
  • Molecular Biology 16.2k
  • Cell Biology 2.9k
  • Endocrinology, Diabetes and Metabolism 2.5k
Replace Phillip Görden with:
Phillip Görden United States
Enrique Rozengurt United Kingdom
Blas Frangione United States
Dudley K. Strickland United States
George G. Glenner United States
Tetsuo Noda Japan
Richard G. Pestell United States
Gunilla T. Westermark Sweden
Maria João Saraiva Portugal
Jan M. van Deursen United States
Per Westermark relative to Phillip Görden United States Phillip Görden's profile →
Citations per field
00.5×7.2×
Phillip Görden · 1×
Citations per year

Countries citing papers authored by Per Westermark

Since Specialization
Citations

This map shows the geographic impact of Per Westermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Westermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Westermark more than expected).

Fields of papers citing papers by Per Westermark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Westermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Westermark. The network helps show where Per Westermark may publish in the future.

Co-authors

The 25 scholars most cited alongside Per Westermark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Westermark Line = papers co-authored together Per Westermark links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 402 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.
Hit paper breakdown →
1987856
2
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Hit paper breakdown →
2011849
3
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Hit paper breakdown →
1990712
4
Fibril in senile systemic amyloidosis is derived from normal transthyretin.
Hit paper breakdown →
1990584
5 2004479
6
Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines
Hit paper breakdown →
2016453
7 1986440
8
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Hit paper breakdown →
2018405
9 1983373
10 2004357
11 1989323
12
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Hit paper breakdown →
2020287
13 2011273
14 2010272
15 2007271
16 2005267
17 1988261
18 1999254
19 2005254
20 2015243

About Per Westermark

Per Westermark is a scholar working on Molecular Biology, Physiology, Surgery, Genetics and Endocrinology, Diabetes and Metabolism, having authored 402 papers that have together received 24.8k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (233 papers), Alzheimer's disease research and treatments (130 papers), Pancreatic function and diabetes (72 papers), Dermatological and Skeletal Disorders (42 papers), Parathyroid Disorders and Treatments (36 papers), Diabetes Treatment and Management (34 papers), Prion Diseases and Protein Misfolding (29 papers) and Trace Elements in Health (26 papers). The work is most often cited by research in Physiology (9.3k citations), Nephrology (1.9k citations), Molecular Biology (16.2k citations), Cell Biology (2.9k citations) and Endocrinology, Diabetes and Metabolism (2.5k citations). Per Westermark has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Gunilla T. Westermark, Knut Sletten, Erik Wilander, Kenneth H. Johnson, Timothy D. O’Brien, Gibbons G. Cornwell, Giampaolo Merlini, Ulla Engström, Christer Wernstedt and Christer Betsholtz. Their work appears in journals such as Amyloid, Biochemical and Biophysical Research Communications, Scandinavian Journal of Immunology, Diabetologia and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact